D
DHR
Danaher Corporation
$224.69
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Danaher Corporation in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
$1.10
Yield
0.49%
EPS
$5.63
P/E
39.3
Data as of Oct 1
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Before the open · Expected EPS: $1.93
Oct 21
About Danaher Corporation
Danaher Corporation makes the instruments, test kits, and lab chemicals that biotech companies, hospitals, and research labs use every day. Instead of selling one-time equipment, much of its revenue comes from the consumables and reagents customers must keep buying to run those machines, which creates a steady stream of repeat business. Its main areas are biotechnology manufacturing tools, life-sciences research equipment, and medical diagnostics. In short, it supplies the behind-the-scenes gear the life-sciences industry runs on, rather than making drugs or treating patients itself.